US News

J&J booster 85% effective against Omicron hospitalisation, S.Africa says

Published by
Reuters

By Tim Cocks JOHANNESBURG (Reuters) -A Johnson and Johnson COVID-19 vaccine booster shot is 85% effective in protecting against being hospitalised by the Omicron variant for 1-2 months after it is received, the head of South Africa’s Medical Research Council (SAMRC) said on Friday. Glenda Gray presented the findings of a SAMRC study at a South African health ministry briefing on the COVID-19 fourth wave, which has been driven by the new variant. “We saw an 85% vaccine effectiveness and we saw that this kind of vaccine effectiveness is maintained for up to two months,” she said. “We are very ha…

Read More

Facebook Comments

Check Also

Mastercard exceeds earnings expectations as consumer spending rebound continues

Jump To The Original Source

Archives